PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trialAndrea Necchi, Filippo de Braud, Daniele Raggi et al.|Investigational New Drugs|2014Cited by 54
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trialAndrea Necchi, Roberto Salvioni, Salvatore Lo Vullo et al.|Annals of Oncology|2017Cited by 46